Latest Intravenous immunoglobulin Stories
KING OF PRUSSIA, Pa., March 19, 2011 /PRNewswire/ -- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a high degree of accuracy and precision.
LOS ANGELES, Feb. 3, 2011 /PRNewswire/ -- Grifols, Inc. today announced that it has expanded the company's PatientCare Program to offer immune globulins (IVIG) to the Primary Immune Deficiency community (PID).
LOS ANGELES, Nov. 22, 2010 /PRNewswire/ -- Grifols today announced availability of its recently approved FlebogammaÂ® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma.
ANAHEIM, Calif., Nov. 18, 2010 /PRNewswire/ -- Crescent Healthcare today announced a planned expansion of their east coast operations in 2011.
RESEARCH TRIANGLE PARK , N.C., Oct. 14 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics (Nasdaq: TLCR) announced today that the U.S.
Scientists report that viral infection of the heart is a predictor of heart transplant failure in young children and adolescents, although it can be detected by screening for viral genes and treated to improve organ survival.
PLYMOUTH, Minn., June 29 /PRNewswire/ -- Midwest Infusion Center expanded from its previous space at West Health by opening a new infusion center at the City Center Professional Building in Plymouth for patients receiving infusion therapy. Midwest Infusion Center is a unique treatment center designed for patients to receive complex therapies in a safe, comfortable and non-clinical setting.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.